CEO Bruno Wohlschlegel:
"We are now doing "Less" - "More!" - Higher forecast after Novartis partnership.
Listen to the Interview
About APONTIS PHARMA
Vision, Mission & Offer
History
Management & Supervisory Board
Corporate Governance
Added Values
Products
Business Development
Career
Investor Relations
Share
Financial Reports
News
Financial Calendar
Annual General Meeting
Presentations
Contact
Contact
DE
EN
News
Here you will find financial news from APONTIS PHARMA as well as other publications relevant to the capital market.
Back
